BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berger KL, Nicholson SA, Dehdashti F, Siegel BA. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol. 2000;174:1005-1008. [PMID: 10749239 DOI: 10.2214/ajr.174.4.1741005] [Cited by in Crossref: 251] [Cited by in F6Publishing: 262] [Article Influence: 10.9] [Reference Citation Analysis]
Number Citing Articles
1 Lin X, Li Y, Wang S, Zhang Y, Chen X, Wei M, Zhu H, Wu A, Yang Z, Wang X. Diagnostic value of [(68)Ga]Ga-FAPI-04 in patients with colorectal cancer in comparison with [(18)F]F-FDG PET/CT. Front Oncol 2022;12:1087792. [PMID: 36698416 DOI: 10.3389/fonc.2022.1087792] [Reference Citation Analysis]
2 Tan CH, Morris VK, Das P, Rodriguez-bigas M, Iyer RB. Colorectal Cancer. Oncologic Imaging : a Multidisciplinary Approach 2023. [DOI: 10.1016/b978-0-323-69538-1.00018-5] [Reference Citation Analysis]
3 Menon N, Mandelkern M. Utility of PET Scans in the Diagnosis and Management of Gastrointestinal Tumors. Dig Dis Sci 2022;67:4633-53. [PMID: 35908126 DOI: 10.1007/s10620-022-07616-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Corr A, Fletcher J, Jenkins J, Miskovic D. Image-guided pelvic exenteration-preoperative and intraoperative strategies. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.08.002] [Reference Citation Analysis]
5 Khader A, Braschi-Amirfarzan M, McIntosh LJ, Gosangi B, Wortman JR, Wald C, Thomas R. Importance of tumor subtypes in cancer imaging. Eur J Radiol Open 2022;9:100433. [PMID: 35909389 DOI: 10.1016/j.ejro.2022.100433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hunt S, Zandifar A, Alavi A. Molecular imaging in management of colorectal metastases by the interventional oncologist. International Journal of Hyperthermia 2022;39:675-81. [DOI: 10.1080/02656736.2021.1998657] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Honka M, Rebelos E, Malaspina S, Nuutila P. Hepatic Positron Emission Tomography: Applications in Metabolism, Haemodynamics and Cancer. Metabolites 2022;12:321. [DOI: 10.3390/metabo12040321] [Reference Citation Analysis]
8 Jiang JY, Kang C, Jackson S, Jeffery N, Winter M, Le K, Mansberg R. A rare case of urachal mucinous adenocarcinoma detected by 18F-FDG PET/CT and MRI. Radiology Case Reports 2022;17:1231-5. [DOI: 10.1016/j.radcr.2022.01.069] [Reference Citation Analysis]
9 Germani MM, Borelli B, Boraschi P, Antoniotti C, Ugolini C, Urbani L, Morelli L, Fontanini G, Masi G, Cremolini C, Moretto R. The management of colorectal liver metastases amenable of surgical resection: How to shape treatment strategies according to clinical, radiological, pathological and molecular features. Cancer Treat Rev 2022;106:102382. [PMID: 35334281 DOI: 10.1016/j.ctrv.2022.102382] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Rogasch JMM, Hofheinz F, van Heek L, Voltin C, Boellaard R, Kobe C. Influences on PET Quantification and Interpretation. Diagnostics 2022;12:451. [DOI: 10.3390/diagnostics12020451] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Boktor RR, Lee ST, Scott AM. PET/CT imaging in colorectal carcinoma. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00033-8] [Reference Citation Analysis]
12 Hayman AV, Vasilevsky C. Colorectal Cancer: Preoperative Evaluation and Staging. The ASCRS Textbook of Colon and Rectal Surgery 2022. [DOI: 10.1007/978-3-030-66049-9_24] [Reference Citation Analysis]
13 Ho CL, Chen S. Oncology: Hepatic cancer. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00109-5] [Reference Citation Analysis]
14 Donkol A, Alsomali RA, Alshammari AM, Alkhamis HA, Alharbi LK, Alhazmi AA, Daiel AAM, Mohzari DAM, Hejres AJ, Alrefaei NA, Alshehri BM. Review on Diagnosis and Management of Colorectal Carcinoma. Clin Cancer Investig J 2022;11:32-35. [DOI: 10.51847/dxsj8lrq5w] [Reference Citation Analysis]
15 Huang A, Yang Y, Shi JY, Li YK, Xu JX, Cheng Y, Gu J. Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer. World J Gastrointest Surg 2021; 13(12): 1567-1583 [DOI: 10.4240/wjgs.v13.i12.1567] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Ahmed IS, El Gaafary SM, Elia RZ, Hussein RS. FDG-PET/CT in predicting aggressiveness of rectal cancer. Egypt J Radiol Nucl Med 2021;52:275. [DOI: 10.1186/s43055-021-00656-1] [Reference Citation Analysis]
17 Seko-Nitta A, Nagatani Y, Murakami Y, Watanabe Y, Nitta N, Murata K, Takemura S, Murata S. 18F-fluorodeoxyglucose uptake in advanced gastric cancer correlates with histopathological subtypes and volume of tumor stroma. Eur J Radiol 2021;145:110048. [PMID: 34814038 DOI: 10.1016/j.ejrad.2021.110048] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Horsley PJ, Sheehan-Dare G, Mastrocostas K, Fung C, Kneebone A, Eade TN, Emmet L, Lalak A, Hruby G. Prostate adenocarcinoma with mucinous features - is it PSMA avid? J Med Imaging Radiat Oncol 2021. [PMID: 34524723 DOI: 10.1111/1754-9485.13327] [Reference Citation Analysis]
19 Lee JI, Cho SS, Shin US, Jeon BH, Moon SM, Kim Y, Yang KY, Kim BI. Implication of FDG-PET/CT without synchronous colonic lesion in patients with stenotic left-sided colorectal cancer. Sci Rep 2021;11:14730. [PMID: 34282192 DOI: 10.1038/s41598-021-94030-w] [Reference Citation Analysis]
20 Dejanovic D, Hansen NL, Loft A. PET/CT Variants and Pitfalls in Gynecological Cancers. Semin Nucl Med 2021:S0001-2998(21)00038-6. [PMID: 34253332 DOI: 10.1053/j.semnuclmed.2021.06.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Alan-Selçuk N, Ergen S, Demirci E, Ocak M, Kabasakal L. [68Ga]DOTA-FAPI-04 PET/CT imaging in a case of a signet ring cell carcinoma of stomach. Eur J Nucl Med Mol Imaging 2021. [PMID: 34148117 DOI: 10.1007/s00259-021-05213-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Virarkar M, Ganeshan D, Gulati AT, Palmquist S, Iyer R, Bhosale P. Diagnostic performance of PET/CT and PET/MR in the management of ovarian carcinoma-a literature review. Abdom Radiol (NY) 2021;46:2323-49. [PMID: 33175199 DOI: 10.1007/s00261-020-02847-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
23 Marin A, Murchison JT, Skwarski KM, Tavares AAS, Fletcher A, Wallace WA, Salapura V, van Beek EJR, Mirsadraee S. Can dynamic imaging, using 18F-FDG PET/CT and CT perfusion differentiate between benign and malignant pulmonary nodules? Radiol Oncol 2021;55:259-67. [PMID: 34051709 DOI: 10.2478/raon-2021-0024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Jayaprakasam VS, Paroder V, Schöder H. Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers. Semin Nucl Med 2021;51:485-501. [PMID: 33965198 DOI: 10.1053/j.semnuclmed.2021.04.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
25 Stokkel LE, Stokkel MPM, Donswijk ML, Lahaye MJ, Bekers EM, van Rhijn BWG, Mertens LS. The Diagnostic Value of FDG-PET/CT for Urachal Cancer. Clin Genitourin Cancer 2021:S1558-7673(21)00065-3. [PMID: 33858788 DOI: 10.1016/j.clgc.2021.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Tahtabasi M, Erturk SM, Basak M. Comparison of MRI and 18F-FDG PET/CT in the Liver Metastases of Gastrointestinal and Pancreaticobiliary Tumors. Sisli Etfal Hastan Tip Bul 2021;55:12-7. [PMID: 33935530 DOI: 10.14744/SEMB.2020.80270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Sasada S, Kimura Y, Masumoto N, Emi A, Kadoya T, Arihiro K, Okada M. Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors. Eur J Surg Oncol 2021;47:1588-92. [PMID: 33685728 DOI: 10.1016/j.ejso.2021.02.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Ward RD, Amorim B, Li W, King J, Umutlu L, Groshar D, Harisinghani M, Catalano O. Abdominal and pelvic 18F-FDG PET/MR: a review of current and emerging oncologic applications. Abdom Radiol (NY) 2021;46:1236-48. [PMID: 32949272 DOI: 10.1007/s00261-020-02766-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Das JP, Vargas HA, Ulaner GA. Mucinous urachal adenocarcinoma: A potential nonfluorodeoxyglucose-avid pitfall on 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography. World J Nucl Med 2020;19:432-4. [PMID: 33623517 DOI: 10.4103/wjnm.WJNM_60_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Queiroz MA, Naves A, Dreyer PR, Cerri GG, Buchpiguel CA. PET/MRI Characterization of Mucinous Versus Nonmucinous Components of Rectal Adenocarcinoma: A Comparison of Tumor Metabolism and Cellularity. AJR Am J Roentgenol 2021;216:376-83. [PMID: 33295813 DOI: 10.2214/AJR.19.22627] [Reference Citation Analysis]
31 Jaykel TJ, Clark MS, Adamo DA, Welch BT, Thompson SM, Young JR, Ehman EC. Thoracic positron emission tomography: 18F-fluorodeoxyglucose and beyond. J Thorac Dis 2020;12:6978-91. [PMID: 33282403 DOI: 10.21037/jtd-2019-cptn-09] [Reference Citation Analysis]
32 Das JP, Vargas HA, Ghafoor S, Goh AC, Ulaner GA. Clinical Utility of 18 F-FDG PET/CT for Staging and Treatment Planning in Urachal Adenocarcinoma. J Nucl Med 2021;62:643-7. [DOI: 10.2967/jnumed.120.251561] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
33 Childs DD, Rocha Lima CMSP, Zhou Y. Mucin-Containing Rectal Cancer: A Review of Unique Imaging, Pathology, and Therapeutic Response Features. Semin Roentgenol 2021;56:186-200. [PMID: 33858645 DOI: 10.1053/j.ro.2020.07.010] [Reference Citation Analysis]
34 Todhe P, Sharma N, Shetty A, Ochieng P. Pulmonary mucinous cystadenocarcinoma: an unusual presentation and literature review. BMJ Case Rep 2020;13:e235567. [PMID: 32675126 DOI: 10.1136/bcr-2020-235567] [Reference Citation Analysis]
35 Ghafoor S, Lakhman Y, Park KJ, Petkovska I. Polypoid endometriosis: a mimic of malignancy. Abdom Radiol (NY) 2020;45:1776-82. [PMID: 31372776 DOI: 10.1007/s00261-019-02143-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
36 Green DB, Wallace AB, Restrepo CS, Merrick DT, Raptis DA, Bhalla S, Vargas D. Fluid-filled Cystic Lesions of the Lungs. J Thorac Imaging 2021;36:208-17. [PMID: 32271279 DOI: 10.1097/RTI.0000000000000507] [Reference Citation Analysis]
37 Ozaki K, Harada K, Terayama N, Kosaka N, Kimura H, Gabata T. FDG-PET/CT imaging findings of hepatic tumors and tumor-like lesions based on molecular background. Jpn J Radiol 2020;38:697-718. [PMID: 32246350 DOI: 10.1007/s11604-020-00961-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
38 Onishi Y, Ito K, Motoi N, Morita T, Watanabe SI, Kusumoto M. Ciliated muconodular papillary tumor of the lung: 18F-FDG PET/CT findings of 15 cases. Ann Nucl Med 2020;34:448-52. [PMID: 32172513 DOI: 10.1007/s12149-020-01457-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
39 Das JP, Vargas HA, Lee A, Hutchinson B, O'Connor E, Kok HK, Torreggiani W, Murphy J, Roche C, Bruzzi J, McCarthy P. The urachus revisited: multimodal imaging of benign & malignant urachal pathology. Br J Radiol 2020;93:20190118. [PMID: 32045264 DOI: 10.1259/bjr.20190118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
40 Elekonawo FMK, Starremans B, Laurens ST, Bremers AJA, de Wilt JHW, Heijmen L, de Geus-Oei LF. Can [18F]F-FDG PET/CT be used to assess the pre-operative extent of peritoneal carcinomatosis in patients with colorectal cancer? Abdom Radiol (NY) 2020;45:301-6. [PMID: 31642963 DOI: 10.1007/s00261-019-02268-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
41 Aytaç E, Aslan F, Çicek B, Erdamar S, Gürses B, Güven K, Falay O, Karahasanoğlu T, Selçukbiricik F, Selek U, Atalar B, Balık E, Tözün N, Rozanes İ, Arıcan A, Hamzaoğlu İ, Baca B, Molinas Mandel N, Saruç M, Göksel S, Demir G, Ağaoğlu F, Yakıcıer C, Özbek U, Özben V, Özyar E, Güner AL, Er Ö, Kaban K, Bölükbaşı Y, Buğra D, Group Tİ. Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group. Turk J Gastroenterol 2019;30:584-98. [PMID: 30541724 DOI: 10.5152/tjg.2018.18737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
42 Assadi M. PET in Gastrointestinal, Pancreatic, and Liver Cancers. Clinical Nuclear Medicine 2020. [DOI: 10.1007/978-3-030-39457-8_19] [Reference Citation Analysis]
43 Cha MJ, Lee KS, Kim TJ, Kim HS, Kim TS, Chung MJ, Kim BT, Kim YS. Solitary Nodular Invasive Mucinous Adenocarcinoma of the Lung: Imaging Diagnosis Using the Morphologic-Metabolic Dissociation Sign. Korean J Radiol 2019;20:513-21. [PMID: 30799583 DOI: 10.3348/kjr.2018.0409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
44 Chan HP, Liu WS, Liou WS, Hu C, Chiu YL, Peng NJ. Comparison of FDG-PET/CT for Cancer Detection in Populations With Different Risks of Underlying Malignancy. In Vivo 2020;34:469-78. [PMID: 31882515 DOI: 10.21873/invivo.11797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
45 Kwon HR, Pahk K, Park S, Kwon HW, Kim S. Prognostic Value of Metabolic Information in Advanced Gastric Cancer Using Preoperative 18F-FDG PET/CT. Nucl Med Mol Imaging 2019;53:386-95. [PMID: 31867074 DOI: 10.1007/s13139-019-00622-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
46 Sánchez-izquierdo N, Perlaza P, Pagès M, Buxó E, Rios J, Rubello D, Colletti PM, Mayoral M, Casanueva S, Fernández-esparrach G, Ginés A, Fuster D. Assessment of Response to Neoadjuvant Chemoradiotherapy by 18F-FDG PET/CT in Patients With Locally Advanced Esophagogastric Junction Adenocarcinoma. Clin Nucl Med 2020;45:38-43. [DOI: 10.1097/rlu.0000000000002840] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
47 Ganeshan D, Nougaret S, Korngold E, Rauch GM, Moreno CC. Locally recurrent rectal cancer: what the radiologist should know. Abdom Radiol (NY) 2019;44:3709-25. [PMID: 30953096 DOI: 10.1007/s00261-019-02003-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
48 Horvat N, Hope TA, Pickhardt PJ, Petkovska I. Mucinous rectal cancer: concepts and imaging challenges. Abdom Radiol (NY) 2019;44:3569-80. [PMID: 30993392 DOI: 10.1007/s00261-019-02019-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
49 Lin AJ, Wright JD, Dehdashti F, Siegel BA, Markovina S, Schwarz J, Thaker PH, Mutch DG, Powell MA, Grigsby PW. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with 18F-fluorodeoxyglucose-positron emission tomography in stage IB cervical cancer. Int J Gynecol Cancer 2019;29:1351-4. [PMID: 31473660 DOI: 10.1136/ijgc-2019-000528] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
50 Koay EJ, Katz MHG, Wang H, Wang X, Prakash L, Javle M, Shroff R, Fogelman D, Avila S, Zaid M, Elganainy D, Lee Y, Crane CH, Krishnan S, Das P, Fleming JB, Lee JE, Tamm EP, Bhosale P, Lee JH, Weston B, Maitra A, Wolff RA, Varadhachary GR. Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer. JCO Precis Oncol 2019;3:PO. [PMID: 32914036 DOI: 10.1200/PO.19.00001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
51 Bosch KD, Chicklore S, Cook GJ, Davies AR, Kelly M, Gossage JA, Baker CR. Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment. Eur J Nucl Med Mol Imaging 2020;47:759-67. [PMID: 31377821 DOI: 10.1007/s00259-019-04429-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
52 Wnorowski AM, Menias CO, Pickhardt PJ, Kim DH, Hara AK, Lubner MG. Mucin-Containing Rectal Carcinomas: Overview of Unique Clinical and Imaging Features. American Journal of Roentgenology 2019;213:26-34. [DOI: 10.2214/ajr.18.20864] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
53 Dolgushin MB, Mikhaylov AI, Gordeev SS. The role of PET/CT with 18F-fluorodeoxyglucose in detecting the progression of colorectal cancer in asymptomatic patients with elevated level of сarcinoembryonic antigen (literature review). Onkol koloproktol 2019;9:11-15. [DOI: 10.17650/2220-3478-2019-9-2-11-15] [Reference Citation Analysis]
54 Colombo N, Sessa C, Bois AD, Ledermann J, McCluggage WG, McNeish I, Morice P, Pignata S, Ray-Coquard I, Vergote I, Baert T, Belaroussi I, Dashora A, Olbrecht S, Planchamp F, Querleu D; ESMO–ESGO Ovarian Cancer Consensus Conference Working Group. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Int J Gynecol Cancer 2019:ijgc-2019-000308. [PMID: 31048403 DOI: 10.1136/ijgc-2019-000308] [Cited by in Crossref: 79] [Cited by in F6Publishing: 89] [Article Influence: 19.8] [Reference Citation Analysis]
55 Flaus A, Longo M, Dematons M, Granjon D, Prevot N. 18F-FDG PET/CT in Urachal Abscess. Clin Nucl Med 2019;44:e349-50. [DOI: 10.1097/rlu.0000000000002524] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
56 Colombo N, Sessa C, du Bois A, Ledermann J, Mccluggage W, Mcneish I, Morice P, Pignata S, Ray-coquard I, Vergote I, Baert T, Belaroussi I, Dashora A, Olbrecht S, Planchamp F, Querleu D, Baert T, Banerjee S, Belaroussi I, Blecharz P, Bruchim I, Cibula D, Colombo N, Concin N, Davidson B, Dashora A, Devouassoux-shisheboran M, du Bois A, Ferrero A, Glasspool R, González-martin A, Heinzelmann-schwarz V, Joly F, Kim J, Kridelka F, Ledermann J, Lorusso D, Mahner S, Mccluggage W, Mcneish I, Mikami M, Mirza M, Morice P, Nicum S, Olbrecht S, O’donnell D, Pautier P, Planchamp F, Pignata S, Querleu D, Ray-coquard I, Rodolakis A, Sehouli J, Selcukbiricik F, Sessa C, Singh N, Tan D, Timmerman D, Tognon G, van der Velden J, Vergote I, Witteveen P, Zeimet A. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Annals of Oncology 2019;30:672-705. [DOI: 10.1093/annonc/mdz062] [Cited by in Crossref: 372] [Cited by in F6Publishing: 404] [Article Influence: 93.0] [Reference Citation Analysis]
57 Mcdermott S, Kilcoyne A, Wang Y, Scott J, Halpern E, Ackman J. Comparison of the 18F-FDG avidity at PET of benign and malignant pure ground-glass opacities: a paradox? Clinical Radiology 2019;74:187-95. [DOI: 10.1016/j.crad.2018.12.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
58 Wong R, Tie J, Lee M, Cohen J, Wang Y, Li L, Ma S, Christie M, Kosmider S, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Gibbs P. The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations. Int J Cancer 2019;145:540-7. [PMID: 30628066 DOI: 10.1002/ijc.32117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
59 O'Neill H, Malik V, Johnston C, Reynolds JV, O'Sullivan J. Can the Efficacy of [18F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles? Pharmaceuticals (Basel) 2019;12:E16. [PMID: 30678034 DOI: 10.3390/ph12010016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
60 Kochhar R, Manoharan P. Role of FDG PET-CT in Colorectal Cancer. Comprehensive Rectal Cancer Care 2019. [DOI: 10.1007/978-3-319-98902-0_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Karaosmanoglu AD, Onur MR, Arellano RS. Imaging in Gastrointestinal Cancers. Textbook of Gastrointestinal Oncology 2019. [DOI: 10.1007/978-3-030-18890-0_25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
62 Catalano O, Kilcoyne A, Signore A, Mahmood U, Rosen B. Lower Gastrointestinal Tract Applications of PET/Computed Tomography and PET/MR Imaging. Radiol Clin North Am 2018;56:821-34. [PMID: 30119776 DOI: 10.1016/j.rcl.2018.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
63 Plodeck V, Rahbari NN, Weitz J, Radosa CG, Laniado M, Hoffmann RT, Zöphel K, Beuthien-Baumann B, Kotzerke J, van den Hoff J, Platzek I. FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences. Eur Radiol 2019;29:422-8. [PMID: 29980927 DOI: 10.1007/s00330-018-5589-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
64 Choi EK, Im JJ, Park CS, Chung Y, Kim K, Oh JK. Usefulness of feature analysis of breast-specific gamma imaging for predicting malignancy. Eur Radiol 2018;28:5195-202. [DOI: 10.1007/s00330-018-5563-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
65 Christianson BE, Gupta S, Vyas SG, Spartz H, Keshavamurthy JH. A diagnostic challenge: An incidental lung nodule in a 48-year-old nonsmoker. Lung India 2018;35:251-5. [PMID: 29697085 DOI: 10.4103/lungindia.lungindia_212_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
66 Han N, Sun X, Qin C, Hassan Bakari K, Wu Z, Zhang Y, Lan X. Value of 18F-FDG PET/CT Combined With Tumor Markers in the Evaluation of Ascites. AJR Am J Roentgenol 2018;210:1155-63. [PMID: 29629798 DOI: 10.2214/AJR.17.18733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
67 Zylberberg HM, Sultan K, Rubin S. Hereditary diffuse gastric cancer: One family’s story. World J Clin Cases 2018; 6(1): 1-5 [PMID: 29376063 DOI: 10.12998/wjcc.v6.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
68 Zhang YJ, Chen JW, He XS, Zhang HZ, Ling YH, Wen JH, Deng WH, Li P, Yun JP, Xie D, Cai MY. SATB2 is a Promising Biomarker for Identifying a Colorectal Origin for Liver Metastatic Adenocarcinomas. EBioMedicine 2018;28:62-9. [PMID: 29396302 DOI: 10.1016/j.ebiom.2018.01.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
69 Omar Carrim Y, Gaxa L, van der Schyff F, Bida NM, Omar F, Lockhat Z. Does radiotherapy prior to surgery improve long term prognosis in pediatric colorectal cancer in lower- and upper-middle income countries with limited resources? Our experience and literature review. J Egypt Natl Canc Inst 2017;29:201-6. [PMID: 29233454 DOI: 10.1016/j.jnci.2017.11.002] [Reference Citation Analysis]
70 Snoeckx A, Dendooven A, Carp L, Desbuquoit D, Spinhoven MJ, Lauwers P, Van Schil PE, van Meerbeeck JP, Parizel PM. Wolf in Sheep’s Clothing: Primary Lung Cancer Mimicking Benign Entities. Lung Cancer 2017;112:109-17. [DOI: 10.1016/j.lungcan.2017.07.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
71 Balyasnikova S, Brown G. Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management. Curr Treat Options Oncol. 2016;17:32. [PMID: 27255100 DOI: 10.1007/s11864-016-0403-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 9.0] [Reference Citation Analysis]
72 Liberale G, Vankerckhove S, Caldon MG, Ahmed B, Moreau M, Nakadi IE, Larsimont D, Donckier V, Bourgeois P; Group R&D for the Clinical Application of Fluorescence Imaging of the Jules Bordetʼs Institute. Fluorescence Imaging After Indocyanine Green Injection for Detection of Peritoneal Metastases in Patients Undergoing Cytoreductive Surgery for Peritoneal Carcinomatosis From Colorectal Cancer: A Pilot Study. Ann Surg 2016;264:1110-5. [PMID: 27828822 DOI: 10.1097/SLA.0000000000001618] [Cited by in Crossref: 83] [Cited by in F6Publishing: 93] [Article Influence: 13.8] [Reference Citation Analysis]
73 Lee SH, Seo JH, Kwon M, Kim JP, Park JJ. Primary Mucinous Carcinoma of the Facial Skin : A Case Report and Literature Review. J Clin Otolaryngol Head Neck Surg 2017;28:110-115. [DOI: 10.35420/jcohns.2017.28.1.110] [Reference Citation Analysis]
74 Verma R, Bhalla AS, Goyal A, Jain D, Loganathan N, Guleria R. Ominous lung cavity “Tambourine sign”. World J Clin Cases 2017; 5(4): 153-158 [PMID: 28470008 DOI: 10.12998/wjcc.v5.i4.153] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
75 Dubreuil J, Giammarile F, Rousset P, Rubello D, Bakrin N, Passot G, Isaac S, Glehen O, Skanjeti A. The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma. Nuclear Medicine Communications 2017;38:312-8. [DOI: 10.1097/mnm.0000000000000649] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
76 Pappo AS, Furman WL. Uncommon Tumors of the Gastrointestinal Tract in Children. Textbook of Uncommon Cancer 2017. [DOI: 10.1002/9781119196235.ch74] [Reference Citation Analysis]
77 Lakhani A, Khan SR, Bharwani N, Stewart V, Rockall AG, Khan S, Barwick TD. FDG PET/CT Pitfalls in Gynecologic and Genitourinary Oncologic Imaging. RadioGraphics 2017;37:577-94. [DOI: 10.1148/rg.2017160059] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 7.5] [Reference Citation Analysis]
78 Kim WS, Lee HS, Lee JM, Kwak MS, Hwang SW, Park SH, Yang DH, Kim KJ, Myung SJ, Yang SK, Byeon JS. Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography for the detection of proximal synchronous lesions in patients with obstructive colorectal cancer. J Gastroenterol Hepatol 2017;32:401-8. [PMID: 27418280 DOI: 10.1111/jgh.13486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
79 Du Y. PET/CT in Colorectal Cancer. PET/CT in Colorectal Cancer 2017. [DOI: 10.1007/978-3-319-54837-1_6] [Reference Citation Analysis]
80 Barbaro B, Leccisotti L, Vecchio FM, Di Matteo M, Serra T, Salsano M, Poscia A, Coco C, Persiani R, Alfieri S, Gambacorta MA, Valentini V, Giordano A, Bonomo L. The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease. Br J Radiol 2017;90:20150836. [PMID: 27845566 DOI: 10.1259/bjr.20150836] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
81 Khan K, Athauda A, Aitken K, Cunningham D, Watkins D, Starling N, Cook GJ, Kalaitzaki E, Chau I, Rao S. Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging. Oncologist 2016;21:1502-8. [PMID: 27742904 DOI: 10.1634/theoncologist.2016-0222] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
82 Flavell RR, Naeger DM, Aparici CM, Hawkins RA, Pampaloni MH, Behr SC. Malignancies with Low Fluorodeoxyglucose Uptake at PET/CT: Pitfalls and Prognostic Importance: Resident and Fellow Education Feature. Radiographics 2016;36:293-4. [PMID: 26761542 DOI: 10.1148/rg.2016150073] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
83 Paspulati RM, Gupta A. PET/MR Imaging in Cancers of the Gastrointestinal Tract. PET Clin 2016;11:403-23. [PMID: 27593246 DOI: 10.1016/j.cpet.2016.05.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
84 Singhal N, Vallam K, Engineer R, Ostwal V, Arya S, Saklani A. Restaging after neoadjuvant chemoradiation in rectal cancers: is histology the key in patient selection? J Gastrointest Oncol 2016;7:360-4. [PMID: 27284467 DOI: 10.21037/jgo.2016.01.08] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
85 dos Anjos DA, Habr-gama A, Vailati BB, Rossi CB, Coturel AE, Perez RO, São Julião GP, de Sousa JB, Buchpiguel CA. 18F-FDG uptake by rectal cancer is similar in mucinous and nonmucinous histological subtypes. Ann Nucl Med 2016;30:513-7. [DOI: 10.1007/s12149-016-1089-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
86 Masai K, Sakurai H, Suzuki S, Asakura K, Nakagawa K, Watanabe S. Clinicopathological features of colloid adenocarcinoma of the lung: A report of six cases: Colloid Adenocarcinoma of the Lung. J Surg Oncol 2016;114:211-5. [DOI: 10.1002/jso.24302] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
87 Dubreuil J, Giammarile F, Rousset P, Bakrin N, Passot G, Isaac S, Glehen O, Skanjeti A. FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei. Eur J Nucl Med Mol Imaging 2016;43:1630-7. [DOI: 10.1007/s00259-016-3347-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
88 Seo HJ, Min BW, Eo JS, Lee SI, Kang SH, Jung SY, Oh SC, Choe JG. Usefulness of (18)F-FDG PET/CT to Detect Metastatic Mucinous Adenocarcinoma Within an Inguinal Hernia. Nucl Med Mol Imaging 2016;50:85-9. [PMID: 26941865 DOI: 10.1007/s13139-015-0379-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
89 Jhaveri KS, Hosseini-Nik H. MRI of Rectal Cancer: An Overview and Update on Recent Advances. AJR Am J Roentgenol. 2015;205:W42-W55. [PMID: 26102418 DOI: 10.2214/ajr.14.14201] [Cited by in Crossref: 91] [Cited by in F6Publishing: 101] [Article Influence: 11.4] [Reference Citation Analysis]
90 Brendle C, Schwenzer NF, Rempp H, Schmidt H, Pfannenberg C, la Fougère C, Nikolaou K, Schraml C. Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series. Eur J Nucl Med Mol Imaging 2016;43:123-32. [DOI: 10.1007/s00259-015-3137-z] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 7.9] [Reference Citation Analysis]
91 Fuster D, Mayoral M, Rubello D, Pineda E, Fernández-Esparrach G, Pagès M, Colletti PM, Pons F. Is there a role for PET/CT with esophagogastric junction adenocarcinoma? Clin Nucl Med. 2015;40:e201-e207. [PMID: 25546207 DOI: 10.1097/RLU.0000000000000661] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
92 Gavra M, Syed R, Fraioli F, Afaq A, Bomanji J. PET/MRI in the Upper Abdomen. Seminars in Nuclear Medicine 2015;45:282-92. [DOI: 10.1053/j.semnuclmed.2015.03.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
93 Calais J, Lussato D, Merlet P. Reply to "18F-Choline PET-CT in the Management of Lung Cancer and Mucinous Tumors?". J Thorac Oncol 2015;10:e49-50. [PMID: 26001152 DOI: 10.1097/JTO.0000000000000527] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
94 Balata H, Evison M, O'Donnell P. Beware of the "Bronchocele," Particularly in Patients with a History or Risk Factors for a Mucinous Carcinoma: A Response to the Article "Resection of a Solitary Pulmonary Metastasis from Prostatic Adenocarcinoma Misdiagnosed as a Bronchocele: Usefulness of 18F-Choline and 18F-FDG PET/CT" by Calais et al. J Thorac Oncol 2015;10:e47-8. [PMID: 26001151 DOI: 10.1097/JTO.0000000000000512] [Reference Citation Analysis]
95 Ambulatory office practice. Clinical Gynecology 2015. [DOI: 10.1017/cbo9781139628938.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
96 Freeman SJ, Sala E. Imaging in gynecology. Clinical Gynecology 2015. [DOI: 10.1017/cbo9781139628938.016] [Reference Citation Analysis]
97 Malibari N, Hickeson M, Lisbona R. PET/Computed Tomography in the Diagnosis and Staging of Gastric Cancers. PET Clin. 2015;10:311-326. [PMID: 26099669 DOI: 10.1016/j.cpet.2015.03.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
98 Kim HW, Won KS, Song BI, Kang YN. Correlation of Primary Tumor FDG Uptake with Histopathologic Features of Advanced Gastric Cancer. Nucl Med Mol Imaging. 2015;49:135-142. [PMID: 26085859 DOI: 10.1007/s13139-015-0327-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
99 Tanizaki Y, Kobayashi A, Shiro M, Ota N, Takano R, Mabuchi Y, Yagi S, Minami S, Terada M, Ino K. Diagnostic value of preoperative SUVmax on FDG-PET/CT for the detection of ovarian cancer. Int J Gynecol Cancer 2014;24:454-60. [PMID: 24463640 DOI: 10.1097/IGC.0000000000000074] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 7.9] [Reference Citation Analysis]
100 Purandare NC, Pramesh CS, Karimundackal G, Jiwnani S, Agrawal A, Shah S, Kulkarni M, Laskar SG, Rangarajan V. Incremental value of 18F-FDG PET/CT in therapeutic decision-making of potentially curable esophageal adenocarcinoma. Nucl Med Commun. 2014;35:864-869. [PMID: 24751701 DOI: 10.1097/MNM.0000000000000137] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
101 Butros SR, Mcdermott S, Shelly MJ, Blake MA. Positron Emission Tomography and Computed Tomography of the Hollow Viscera. Textbook of Gastrointestinal Radiology, 2-Volume Set 2015. [DOI: 10.1016/b978-1-4557-5117-4.00007-6] [Reference Citation Analysis]
102 Jee KN. Duodenal Mucinous Carcinoma: A Case Report. J Korean Soc Radiol 2015;72:185. [DOI: 10.3348/jksr.2015.72.3.185] [Reference Citation Analysis]
103 Speirs CK, Grigsby PW, Huang J, Thorstad WL, Parikh PJ, Robinson CG, Bradley JD. PET-based radiation therapy planning. PET Clin 2015;10:27-44. [PMID: 25455878 DOI: 10.1016/j.cpet.2014.09.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
104 Karantanis D, Kalkanis D, Czernin J, Herrmann K, Pomykala KL, Bogsrud TV, Subramaniam RM, Lowe VJ, Allen-Auerbach MS. Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physicians. J Nucl Med 2014;55:1925-9. [PMID: 25453041 DOI: 10.2967/jnumed.114.145607] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
105 Montravers F, Loi V. Apport de la TEP/TDM au FDG en cancérologie de l’intestin grêle. Médecine Nucléaire 2014;38:369-374. [DOI: 10.1016/j.mednuc.2014.08.001] [Reference Citation Analysis]
106 Caglar M, Yener C, Karabulut E. Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer. Int J Comput Assist Radiol Surg 2015;10:993-1002. [PMID: 25213271 DOI: 10.1007/s11548-014-1115-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
107 Puranik AD, Purandare NC, Agrawal A, Shah S, Rangarajan V. Imaging spectrum of peritoneal carcinomatosis on FDG PET/CT. Jpn J Radiol 2014;32:571-8. [DOI: 10.1007/s11604-014-0346-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
108 Mazzei MA, Khader L, Cirigliano A, Cioffi Squitieri N, Guerrini S, Forzoni B, Marrelli D, Roviello F, Mazzei FG, Volterrani L. Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Abdom Imaging. 2013;38:1422-1430. [PMID: 23744439 DOI: 10.1007/s00261-013-0013-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 5.2] [Reference Citation Analysis]
109 Keu KV, Iagaru AH. The clinical use of PET/CT in the evaluation of melanoma. Methods Mol Biol 2014;1102:553-80. [PMID: 24258999 DOI: 10.1007/978-1-62703-727-3_30] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
110 Kang J, Jeon TJ, Yoon SO, Lee KY, Sohn SK. An extragastrointestinal stromal tumor in the omentum with peritoneal seeding mimicking an appendiceal mucinous cancer with carcinomatosis. Ann Coloproctol 2014;30:93-6. [PMID: 24851220 DOI: 10.3393/ac.2014.30.2.93] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
111 Rachh S, Basu S. PET/CT in patients with liver lesions of different nature. Clin Transl Imaging 2014;2:139-55. [DOI: 10.1007/s40336-014-0061-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
112 Sunderland GJ, Dunne DF, Jones RP, Malik HZ, Poston GJ, Fenwick SW. Current management of colorectal liver metastases. Colorectal Cancer 2014;3:163-181. [DOI: 10.2217/crc.13.86] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
113 Wiegering A, Herrmann K, Bluemel C, Buck AK, Germer CT. [Importance of FDG-PET/CT for surgery of rectal cancer]. Chirurg 2014;85:487-92. [PMID: 24663346 DOI: 10.1007/s00104-013-2669-7] [Reference Citation Analysis]
114 Puranik AD, Purandare N, Agrawal A, Shah S, Rangarajan V. Bone Marrow Metastases in an Otherwise Operable Gall Bladder Cancer: Rare Site of Distant Metastases Detected on FDG PET/CT. Clinical Nuclear Medicine 2014;39:e169-72. [DOI: 10.1097/rlu.0b013e3182817cfb] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
115 Partovi S, Kohan A, Paspulati RM, Ros PR, Herrmann KA. PET/MR in Colorectal Cancer. PET/MRI 2014. [DOI: 10.1007/978-3-642-40692-8_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
116 Dunne DF, Jones RP, Malik HZ, Fenwick SW, Poston GJ. Surgical management of colorectal liver metastases: a European perspective. Hepat Oncol. 2014;1:121-133. [PMID: 30190946 DOI: 10.2217/hep.13.3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
117 An YS, Lee DH, Yoon JK, Lee SJ, Kim TH, Kang DK, Kim KS, Jung YS, Yim H. Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients. Nuklearmedizin 2014;53:89-94. [PMID: 24220324 DOI: 10.3413/Nukmed-0605-13-06] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
118 Schwenzer NF, Schmidt H, Gatidis S, Brendle C, Müller M, Königsrainer I, Claussen CD, Pfannenberg AC, Schraml C. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET. J Magn Reson Imaging 2014;40:1121-8. [PMID: 24923481 DOI: 10.1002/jmri.24497] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
119 Kadhim LA, Dholakia AS, Herman JM, Wahl RL, Chaudhry MA. The role of 18F-fluorodeoxyglucose positron emission tomography in the management of patients with pancreatic adenocarcinoma. J Radiat Oncol 2013;2:341-52. [PMID: 29423019 DOI: 10.1007/s13566-013-0130-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
120 Nural MS, Danaci M, Soyucok A, Okumus NO. Efficiency of apparent diffusion coefficients in differentiation of colorectal tumor recurrences and posttherapeutical soft-tissue changes. European Journal of Radiology 2013;82:1702-9. [DOI: 10.1016/j.ejrad.2013.05.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
121 Hu J, Zhang X, Li B, Zhang M, Wang C, Chen G. The clinical value of 18F-FDG PET/CT in the evaluation of bone metastases undetermined origin. Clin Imaging 2013;37:922-4. [PMID: 23849830 DOI: 10.1016/j.clinimag.2013.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
122 Amin A, Reddy A, Wilson R, Jha M, Miranda S, Amin J. Unnecessary surgery can be avoided by judicious use of PET/CT scanning in colorectal cancer patients. J Gastrointest Cancer 2012;43:594-8. [PMID: 22552946 DOI: 10.1007/s12029-012-9391-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
123 Takebayashi R, Izuishi K, Yamamoto Y, Kameyama R, Mori H, Masaki T, Suzuki Y. [18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer. J Exp Clin Cancer Res. 2013;32:34. [PMID: 23718763 DOI: 10.1186/1756-9966-32-34] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
124 Culverwell AD, Chowdhury FU, Scarsbrook AF. Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer. Abdom Imaging 2012;37:1021-31. [PMID: 22371087 DOI: 10.1007/s00261-012-9855-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
125 Ma Q, Xin J, Zhao Z, Guo Q, Yu S, Xu W, Liu C, Zhai W. Value of 18F-FDG PET/CT in the diagnosis of primary gastric cancer via stomach distension. Eur J Radiol. 2013;82:e302-e306. [PMID: 23434453 DOI: 10.1016/j.ejrad.2013.01.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
126 Choi YA, Lee HY, Han J, Choi JY, Kim J, Kwon OJ, Lee KS. Pulmonary mucinous cystadenocarcinoma: report a case and review of CT findings. Korean J Radiol 2013;14:384-8. [PMID: 23483761 DOI: 10.3348/kjr.2013.14.2.384] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
127 Sharma B, Martin A, Zerizer I. Positron Emission Tomography-Computed Tomography in Liver Imaging. Seminars in Ultrasound, CT and MRI 2013;34:66-80. [DOI: 10.1053/j.sult.2012.11.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
128 Granov A, Tiutin L, Schwarz T. Colorectal Cancer. Positron Emission Tomography 2013. [DOI: 10.1007/978-3-642-21120-1_8] [Reference Citation Analysis]
129 Chong A, Song HC, Oh JR, Ha JM, Min JJ, Bom HS, Choi YD, Lee JS. Gelatinous degeneration of the bone marrow mimicking osseous metastasis on 18F-FDG PET/CT. Clin Nucl Med. 2012;37:798-800. [PMID: 22785516 DOI: 10.1097/rlu.0b013e31825ae455] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
130 Liong SY, Kochhar R, Renehan AG, Manoharan P. Utility of 18-fluorodeoxyglucose positron emission/computed tomography in the management of recurrent colorectal cancer: PET/CT in recurrent colorectal cancer. ANZ J Surg 2012;82:729-36. [DOI: 10.1111/j.1445-2197.2012.06237.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
131 Gámez Cenzano C, Sabaté Llobera A, Narváez García JA, Rodríguez Bel L, García del Muro FJ. [Positron emission tomography-computed tomography in tumors of the locomotor apparatus]. Radiologia 2012;54 Suppl 1:3-13. [PMID: 22959330 DOI: 10.1016/j.rx.2012.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
132 Toriihara A, Taniguchi Y, Negi M, Kubota K, Makino T, Shibuya H. FDG PET/CT of a benign ovarian Brenner tumor. Clinical Imaging 2012;36:650-3. [DOI: 10.1016/j.clinimag.2011.12.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
133 Antunovic L, Cimitan M, Borsatti E, Baresic T, Sorio R, Giorda G, Steffan A, Balestreri L, Tatta R, Pepe G, Rubello D, Cecchin D, Canzonieri V. Revisiting the Clinical Value of 18F-FDG PET/CT in Detection of Recurrent Epithelial Ovarian Carcinomas: Correlation With Histology, Serum CA-125 Assay, and Conventional Radiological Modalities. Clinical Nuclear Medicine 2012;37:e184-8. [DOI: 10.1097/rlu.0b013e31825b2583] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
134 Bozkurt M, Okutur K, Aydin K, Namal E, Oztürk A, Balci C, Demir G. Locally metastatic mucinous rectal adenocarcinoma: Imaging diagnosis with DW-MRI in comparison with PET-CT. Oncol Lett 2012;3:1311-3. [PMID: 22783440 DOI: 10.3892/ol.2012.663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
135 Onitilo AA, Aryal G, Engel JM. Hereditary diffuse gastric cancer: a family diagnosis and treatment. Clin Med Res. 2013;11:36-41. [PMID: 22723466 DOI: 10.3121/cmr.2012.1071] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
136 Uchiyama S, Haruyama Y, Asada T, Hotokezaka M, Nagamachi S, Chijiiwa K. Role of the standardized uptake value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in detecting the primary tumor and lymph node metastasis in colorectal cancers. Surg Today 2012;42:956-61. [PMID: 22711186 DOI: 10.1007/s00595-012-0225-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
137 Lee JW, Lee SM, Lee MS, Shin HC. Role of 18F-FDG PET/CT in the prediction of gastric cancer recurrence after curative surgical resection. Eur J Nucl Med Mol Imaging. 2012;39:1425-1434. [PMID: 22673973 DOI: 10.1007/s00259-012-2164-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
138 Panagiotidis E, Datseris IE, Exarhos D, Skilakaki M, Skoura E, Bamias A. High incidence of peritoneal implants in recurrence of intra-abdominal cancer revealed by 18F-FDG PET/CT in patients with increased tumor markers and negative findings on conventional imaging. Nucl Med Commun 2012;33:431-8. [PMID: 22293498 DOI: 10.1097/MNM.0b013e3283506ae1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
139 Au-Yeung AW, Luk WH, Lo AX. Imaging features of colorectal liver metastasis in FDG PET-CT: a retrospective correlative analysis between CT attenuation and FDG uptake. Nucl Med Commun 2012;33:403-7. [PMID: 22273638 DOI: 10.1097/MNM.0b013e32834f4d54] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
140 Montravers F, Talbot J. Tomographie par émission de positons en cancérologie digestive. EMC - Radiologie et imagerie médicale - Abdominale - Digestive 2012;7:1-14. [DOI: 10.1016/s1879-8527(12)55045-8] [Reference Citation Analysis]
141 Perez RO, Habr-Gama A, São Julião GP, Gama-Rodrigues J, Sousa AH, Campos FG, Imperiale AR, Lynn PB, Proscurshim I, Nahas SC. Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks? Int J Radiat Oncol Biol Phys. 2012;84:1159-1165. [PMID: 22580120 DOI: 10.1016/j.ijrobp.2012.01.096] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
142 Goldberg J, Furman WL. Management of Colorectal Carcinoma in Children and Young Adults. Journal of Pediatric Hematology/Oncology 2012;34:S76-9. [DOI: 10.1097/mph.0b013e31824e38c1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
143 De Gaetano AM, Rufini V, Castaldi P, Gatto AM, Filograna L, Giordano A, Bonomo L. Clinical applications of 18F-FDG PET in the management of hepatobiliary and pancreatic tumors. Abdom Imaging 2012;37:983-1003. [DOI: 10.1007/s00261-012-9845-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
144 Yang Z, Pan L, Cheng J, Hu S, Xu J, Ye D, Zhang Y. Clinical value of whole body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of metastatic bladder cancer: FDG-PET metastatic bladder cancer. International Journal of Urology 2012;19:639-44. [DOI: 10.1111/j.1442-2042.2012.02989.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
145 Pappo AS, Furman WL. Uncommon Tumors of the Gastrointestinal Tract in Children. Textbook of Uncommon Cancer 2012. [DOI: 10.1002/9781118464557.ch64] [Reference Citation Analysis]
146 Tan CH, Das P, Silberfein EJ, Rodriguez-bigas M, Iyer RB. Colorectal Cancer. Oncologic Imaging: A Multidisciplinary Approach 2012. [DOI: 10.1016/b978-1-4377-2232-1.00017-6] [Reference Citation Analysis]
147 Loevner LA. Integrated PET-CT and PET-MR: Pitfalls and Applications in Head and Neck Squamous Cell Carcinoma. Diseases of the Brain, Head & Neck, Spine 2012–2015 2012. [DOI: 10.1007/978-88-470-2628-5_34] [Reference Citation Analysis]
148 Grassetto G, Marzola MC, Minicozzi A, Al-Nahhas A, Rubello D. F-18 FDG PET/CT in rectal carcinoma: where are we now? Clin Nucl Med. 2011;36:884-888. [PMID: 21892038 DOI: 10.1097/rlu.0b013e318219b507] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
149 Yang Z, Hu S, Shi W, Zhu B, Xu J, Zhang Y. The clinical value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in postoperative patients with gastrointestinal mucinous adenocarcinoma. Nuclear Medicine Communications 2011;32:1018-25. [DOI: 10.1097/mnm.0b013e32834bbd22] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
150 Long NM, Smith CS. Causes and imaging features of false positives and false negatives on F-PET/CT in oncologic imaging. Insights Imaging 2011;2:679-98. [PMID: 22347986 DOI: 10.1007/s13244-010-0062-3] [Cited by in Crossref: 92] [Cited by in F6Publishing: 103] [Article Influence: 7.7] [Reference Citation Analysis]
151 Cafagna D, Rubini G, Iuele F, Maggialetti N, Notaristefano A, Pinto D, Niccoli-asabella A, Palmiotti G, Lasciarrea M, Maggialetti A. Whole-body MR-DWIBS vs. [18F]-FDG-PET/CT in the study of malignant tumors: a retrospective study. Radiol med 2012;117:293-311. [DOI: 10.1007/s11547-011-0708-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
152 Oh HH, Lee SE, Choi IS, Choi WJ, Yoon DS, Min HS, Ra YM, Moon JI, Kang YH. The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer. J Surg Oncol 2011;104:530-3. [PMID: 21618250 DOI: 10.1002/jso.21985] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
153 Shiono S, Abiko M, Sato T. Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers. J Thorac Oncol 2011;6:43-7. [PMID: 21079522 DOI: 10.1097/JTO.0b013e3181f9abca] [Cited by in Crossref: 53] [Cited by in F6Publishing: 60] [Article Influence: 4.4] [Reference Citation Analysis]
154 Ambrosini V, Nicolini S, Caroli P, Nanni C, Massaro A, Marzola MC, Rubello D, Fanti S. PET/CT imaging in different types of lung cancer: an overview. Eur J Radiol 2012;81:988-1001. [PMID: 21458181 DOI: 10.1016/j.ejrad.2011.03.020] [Cited by in Crossref: 99] [Cited by in F6Publishing: 85] [Article Influence: 8.3] [Reference Citation Analysis]
155 Stroobants S. PET/CT for Staging and Diagnosis of Lung Cancer. Medical Radiology 2011. [DOI: 10.1007/174_2011_323] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
156 Loevner LA. PET-CT/MR Imaging in Head and Neck Cancer: Physiologic Variations, Pitfalls, and Directed Applications. Functional Neuroradiology 2011. [DOI: 10.1007/978-1-4419-0345-7_41] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
157 Ledermann JA, Raja FA. Mucinous Cancers: Ovary. Rare and Uncommon Gynecological Cancers 2011. [DOI: 10.1007/978-3-642-13492-0_5] [Reference Citation Analysis]
158 Delbeke D, Martin WH. FDG PET and PET/CT for Colorectal Cancer. Methods in Molecular Biology 2011. [DOI: 10.1007/978-1-61779-062-1_6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
159 Rohani P, Scotti SD, Shen P, Stewart JH, Russell GB, Cromer M, Levine EA. Use of FDG-PET Imaging for Patients with Disseminated Cancer of the Appendix. The American Surgeon 2010;76:1338-44. [DOI: 10.1177/000313481007601217] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
160 Shim SS, Kim Y, Ryu YJ. Novel influenza A (H1N1) infection: chest CT findings from 21 cases in Seoul, Korea. Clin Radiol 2011;66:118-24. [PMID: 21216327 DOI: 10.1016/j.crad.2010.07.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
161 Bhosale P, Peungjesada S, Wei W, Levenback CF, Schmeler K, Rohren E, Macapinlac HA, Iyer RB. Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels. Int J Gynecol Cancer 2010;20:936-44. [PMID: 20683399 DOI: 10.1111/IGC.0b013e3181e82a7f] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
162 Gu J, Khong PL, Wang S, Chan Q, Law W, Zhang J. Quantitative assessment of diffusion-weighted MR imaging in patients with primary rectal cancer: correlation with FDG-PET/CT. Mol Imaging Biol. 2011;13:1020-1028. [PMID: 20872077 DOI: 10.1007/s11307-010-0433-7] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 4.8] [Reference Citation Analysis]
163 Alakus H, Batur M, Schmidt M, Drebber U, Baldus SE, Vallböhmer D, Prenzel KL, Metzger R, Bollschweiler E, Hölscher AH. Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression. Nucl Med Commun. 2010;31:532-538. [PMID: 20220543 DOI: 10.1097/mnm.0b013e32833823ac] [Cited by in Crossref: 60] [Cited by in F6Publishing: 68] [Article Influence: 4.6] [Reference Citation Analysis]
164 Kyriazi S, Kaye SB, deSouza NM. Imaging ovarian cancer and peritoneal metastases—current and emerging techniques. Nat Rev Clin Oncol 2010;7:381-93. [DOI: 10.1038/nrclinonc.2010.47] [Cited by in Crossref: 82] [Cited by in F6Publishing: 89] [Article Influence: 6.3] [Reference Citation Analysis]
165 Shim SS, Han J. FDG-PET/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlation. Ann Nucl Med 2010;24:357-62. [PMID: 20306161 DOI: 10.1007/s12149-010-0358-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
166 Weston BR, Iyer RB, Qiao W, Lee JH, Bresalier RS, Ross WA. Ability of integrated positron emission and computed tomography to detect significant colonic pathology: The experience of a tertiary cancer center. Cancer 2010;116:1454-61. [DOI: 10.1002/cncr.24885] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
167 Shyn PB, Madan R, Wu C, Erturk SM, Silverman SG. PET/CT pattern analysis for surgical staple line recurrence in patients with colorectal cancer. AJR Am J Roentgenol 2010;194:414-21. [PMID: 20093604 DOI: 10.2214/AJR.09.2892] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
168 Delbeke D, Walker RC. Colorectal Cancer. Hybrid PET/CT and SPECT/CT Imaging 2010. [DOI: 10.1007/978-0-387-92820-3_7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
169 Yeh C, Chen Y. Utility of FDG Metabolism to Differentiate Synchronous Metastatic Liver Lesions From Synchronous Colon Cancer: Nonmucinous Versus Mucinous Adenocarcinoma. Clinical Nuclear Medicine 2010;35:44-6. [DOI: 10.1097/rlu.0b013e3181c361c4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
170 Kang YJ, Heo SH, Kim JW, Shin SS, Chang NK, Choi S, Cho CK, Bom HS, Jeong YY, Kang HK. Detection of Intra-Abdominal Tumor Recurrence in Patients with Cholangiocarcinoma: Comparison of Contrast-Enhanced MDCT and18F FDG-PET/CT. J Korean Soc Radiol 2010;62:149. [DOI: 10.3348/jksr.2010.62.2.149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
171 Metrard G, Morel O, Girault S, Soulie P, Guerin-meyer V, Lorimier G, Jeanguillaume C, Berthelot C, Parot-schinkel E, Le Jeune J, Gamelin E. Évaluation de la TEP au 18F-FDG dans l’exploration de la récidive des carcinomes colorectaux. Médecine Nucléaire 2009;33:547-52. [DOI: 10.1016/j.mednuc.2009.06.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
172 Gadducci A, Cosio S. Surveillance of patients after initial treatment of ovarian cancer. Crit Rev Oncol Hematol 2009;71:43-52. [PMID: 19179092 DOI: 10.1016/j.critrevonc.2008.12.008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
173 Loevner LA, Kim AK, Mikityansky I. PET/CT-MR Imaging in Head and Neck Cancer Including Pitfalls and Physiologic Variations. PET Clin 2008;3:335-53. [PMID: 27156665 DOI: 10.1016/j.cpet.2009.04.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
174 Yoshida Y, Kurokawa T, Tsujikawa T, Okazawa H, Kotsuji F. Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16alpha-18F-fluoro-17beta-estradiol PET. J Ovarian Res. 2009;2:7. [PMID: 19527525 DOI: 10.1186/1757-2215-2-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
175 Risum S, Høgdall C, Markova E, Berthelsen AK, Loft A, Jensen F, Høgdall E, Roed H, Engelholm SA. Influence of 2-(18F) Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography/Computed Tomography on Recurrent Ovarian Cancer Diagnosis and on Selection of Patients for Secondary Cytoreductive Surgery: . International Journal of Gynecological Cancer 2009;19:600-4. [DOI: 10.1111/igc.0b013e3181a3cc94] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 3.0] [Reference Citation Analysis]
176 Schwarz JK, Grigsby PW, Dehdashti F, Delbeke D. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries. J Nucl Med. 2009;50 Suppl 1:64S-73S. [PMID: 19380409 DOI: 10.2967/jnumed.108.057257] [Cited by in Crossref: 87] [Cited by in F6Publishing: 88] [Article Influence: 6.2] [Reference Citation Analysis]
177 Gerritsen KG, Slee PH, Bollen TL, van Hecke W, Seldenrijk CA, Keijsers RG, Duurkens VA. Recurrent pneumonia due to an appendiceal mucinous cystadenocarcinoma: a rare presentation of a rare malignancy. Clin Med Oncol 2009;3:9-12. [PMID: 20689604 DOI: 10.4137/cmo.s1178] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
178 Pfannenberg C, Königsrainer I, Aschoff P, Öksüz MÖ, Zieker D, Beckert S, Symons S, Nieselt K, Glatzle J, Weyhern CV, Brücher BL, Claussen CD, Königsrainer A. 18F-FDG-PET/CT to Select Patients with Peritoneal Carcinomatosis for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol 2009;16:1295-303. [DOI: 10.1245/s10434-009-0387-7] [Cited by in Crossref: 109] [Cited by in F6Publishing: 116] [Article Influence: 7.8] [Reference Citation Analysis]
179 Chun EJ, Lee HJ, Kang WJ, Kim KG, Goo JM, Park CM, Lee CH. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT. Lung Cancer 2009;65:180-6. [PMID: 19155090 DOI: 10.1016/j.lungcan.2008.11.015] [Cited by in Crossref: 54] [Cited by in F6Publishing: 65] [Article Influence: 3.9] [Reference Citation Analysis]
180 Metser U. Positron Emission Tomography and Colorectal Cancer. Colorectal Cancer 2009. [DOI: 10.1007/978-1-4020-9545-0_13] [Reference Citation Analysis]
181 Nishizawa S, Inubushi M, Kido A, Miyagawa M, Inoue T, Shinohara K, Kajihara M. Incidence and characteristics of uterine leiomyomas with FDG uptake. Ann Nucl Med. 2008;22:803-810. [PMID: 19039559 DOI: 10.1007/s12149-008-0184-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
182 Belcher E, Nicholson AG, Hansell DM, Goldstraw P. Imaging Characteristics of a Mucinous Colorectal Pulmonary Metastasis. The Annals of Thoracic Surgery 2008;86:1698. [DOI: 10.1016/j.athoracsur.2007.12.078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
183 Vikram R, Iyer RB. PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer. Cancer Imaging 2008;8 Spec No A:S46-51. [PMID: 18852081 DOI: 10.1102/1470-7330.2008.9009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
184 Paradela S, Castiñeiras I, Cuevas J, Almagro M, Pozo JD, Fonseca E. Mucinous Carcinoma of the Skin: Evaluation of Lymphatic Invasion With D2-40. The American Journal of Dermatopathology 2008;30:504-8. [DOI: 10.1097/dad.0b013e318170c3cf] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
185 Pinilla I, Rodríguez-Vigil B, Gómez-León N. Integrated FDG PET/CT: Utility and Applications in Clinical Oncology. Clin Med Oncol 2008;2:181-98. [PMID: 21892279 DOI: 10.4137/cmo.s504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
186 Goudarzi B, Jacene HA, Wahl RL. Diagnosis and Differentiation of Bronchioloalveolar Carcinoma from Adenocarcinoma with Bronchioloalveolar Components with Metabolic and Anatomic Characteristics Using PET/CT. J Nucl Med 2008;49:1585-92. [DOI: 10.2967/jnumed.108.052712] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
187 Saab R, Furman WL. Epidemiology and management options for colorectal cancer in children. Paediatr Drugs 2008;10:177-92. [PMID: 18454570 DOI: 10.2165/00148581-200810030-00006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
188 Spencer J. Indeterminate lesions in cancer imaging. Clinical Radiology 2008;63:843-52. [DOI: 10.1016/j.crad.2007.11.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
189 Nakajo M, Jinnouchi S, Arimura H, Kitajima S, Tateno R, Nakajo M. FDG PET/CT Findings of Urachal Abscess. Clinical Nuclear Medicine 2008;33:579-81. [DOI: 10.1097/rlu.0b013e31817dead5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
190 Shin SS, Jeong YY, Min JJ, Kim HR, Chung TW, Kang HK. Preoperative staging of colorectal cancer: CT vs. integrated FDG PET/CT. Abdom Imaging. 2008;33:270-277. [PMID: 17610107 DOI: 10.1007/s00261-007-9262-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
191 Baiocchi GL, Portolani N, Bertagna F, Gheza F, Pizzocaro C, Giubbini R, Giulini SM. Possible additional value of 18FDG-PET in managing pancreas intraductal papillary mucinous neoplasms: preliminary results. J Exp Clin Cancer Res. 2008;27:10. [PMID: 18577196 DOI: 10.1186/1756-9966-27-10] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
192 Lonneux M. FDG-PET and PET/CT in Colorectal Cancer. PET Clinics 2008;3:147-53. [DOI: 10.1016/j.cpet.2008.08.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
193 Talbot J, Montravers F, Gutman F, Kerrou K, Huchet V, Grahek D, Andre T, Houry S, Touboul E, Rosmorduc O, Poupon R, Ruszniewski P, Rougier P, Grange J. Tomographie par émission de positons et cancers digestifs. La Presse Médicale 2008;37:e1-e24. [DOI: 10.1016/j.lpm.2007.03.048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
194 Dresel S, Schlag PM. PET in Colorectal Cancer. PET in Oncology 2008. [DOI: 10.1007/978-3-540-31203-1_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
195 Suga K. Feasibility of F-18-FDG PET/CT Scan for in Abdomino-pelvic Regions -The 2<sup>nd</sup> Chapter-. Yamaguchi Medical Journal 2008;57:171-184. [DOI: 10.2342/ymj.57.171] [Reference Citation Analysis]
196 Chatzifotiadis DN, Buchanan JW, Wahl RL. Positron Emission Tomography and Cancer. Oncology. [DOI: 10.1007/0-387-31056-8_33] [Reference Citation Analysis]
197 Amthauer H, Ruf J. Nuclear Medical Methods for the Diagnosis of Pancreatic Cancer: Positron Emission Tomography. Pancreatic Cancer. [DOI: 10.1007/978-3-540-71279-4_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
198 Nusair S, Rubinstein R, Freedman NM, Amir G, Bogot NR, Izhar U, Breuer R. Positron emission tomography in interstitial lung disease. Respirology 2007;12:843-7. [DOI: 10.1111/j.1440-1843.2007.01143.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
199 Tuncel M. Correspondence: diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions. Nucl Med Commun 2007;28:879-80; author reply 880. [PMID: 17901773 DOI: 10.1097/MNM.0b013e3282f12698] [Reference Citation Analysis]
200 Mahmood U, Upadhyay R. Current and Future Imaging Paradigms in Colorectal Cancer. Semin Colon Rectal Surg 2007;18:132-8. [PMID: 18516215 DOI: 10.1053/j.scrs.2007.03.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
201 Delbeke D, Komori T, Martin WH. Colorectal Carcinoma. Practical FDG Imaging: A Teaching File. [DOI: 10.1007/978-0-387-22453-4_10] [Reference Citation Analysis]
202 Kuzucu M, Martin WH, Delbeke D. Lung Tumors. Practical FDG Imaging: A Teaching File. [DOI: 10.1007/978-0-387-22453-4_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
203 Khandani AH, Whitney KD, Keller SM, Isasi CR, Donald Blaufox M. Sensitivity of FDG PET, GLUT1 expression and proliferative index in bronchioloalveolar lung cancer. Nucl Med Commun. 2007;28:173-177. [PMID: 17264775 DOI: 10.1097/MNM.0b013e328013ebc5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
204 Bhure U, Schmitt AM, Pestalozzi BC, Hany TF, Strobel K. FDG-Negative Signet Ring Cell Cancer of the Stomach With FDG-Positive Skin Metastases. Clinical Nuclear Medicine 2007;32:226-8. [DOI: 10.1097/01.rlu.0000255241.97811.4d] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
205 Blodgett TM, Meltzer CC, Townsend DW. PET/CT: form and function. Radiology. 2007;242:360-385. [PMID: 17255408 DOI: 10.1148/radiol.2422051113] [Cited by in Crossref: 285] [Cited by in F6Publishing: 305] [Article Influence: 17.8] [Reference Citation Analysis]
206 Luciani A, Jourdan G, Itti E, Tran Van Nhieu J, Djabbari M, Zegai B, Karoui M, Anglade M, Rahmouni A. Imagerie des métastases hépatiques. EMC - Radiologie et imagerie médicale - Abdominale - Digestive 2007;2:1-18. [DOI: 10.1016/s1879-8527(07)72818-6] [Reference Citation Analysis]
207 Gadducci A, Cosio S, Zola P, Landoni F, Maggino T, Sartori E. Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature. Int J Gynecol Cancer 2007;17:21-31. [DOI: 10.1111/j.1525-1438.2007.00826.x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 95] [Article Influence: 5.6] [Reference Citation Analysis]
208 Mutch MG, Birnbaum EH, Menias CO. Diagnostic Evaluations—Radiology, Nuclear Scans, PET, CT Colography. The ASCRS Textbook of Colon and Rectal Surgery 2007. [DOI: 10.1007/978-0-387-36374-5_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
209 Gu J, Yamamoto H, Fukunaga H, Danno K, Takemasa I, Ikeda M, Tatsumi M, Sekimoto M, Hatazawa J, Nishimura T, Monden M. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer. Dig Dis Sci 2006;51:2198-205. [PMID: 17080242 DOI: 10.1007/s10620-006-9428-2] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 3.6] [Reference Citation Analysis]
210 de Geus-Oei LF, Ruers TJ, Punt CJ, Leer JW, Corstens FH, Oyen WJ. FDG-PET in colorectal cancer. Cancer Imaging 2006;6:S71-81. [PMID: 17114081 DOI: 10.1102/1470-7330.2006.9014] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
211 Rigo P, Hustinx R, Bury T. PET and PET/CT Imaging in Lung Cancer. Positron Emission Tomography. [DOI: 10.1007/1-84628-187-3_7] [Reference Citation Analysis]
212 Blake MA, Singh A, Setty BN, Slattery J, Kalra M, Maher MM, Sahani DV, Fischman AJ, Mueller PR. Pearls and Pitfalls in Interpretation of Abdominal and Pelvic PET-CT. RadioGraphics 2006;26:1335-53. [DOI: 10.1148/rg.265055208] [Cited by in Crossref: 79] [Cited by in F6Publishing: 86] [Article Influence: 4.6] [Reference Citation Analysis]
213 Montravers F, Grahek D, Kerrou K, Gutman F, Talbot JN. [Positron emission tomography (PET) in gastrointestinal cancer]. Gastroenterol Clin Biol 2006;30:737-41. [PMID: 16801895 DOI: 10.1016/s0399-8320(06)73306-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
214 Chang JM, Lee HJ, Goo JM, Lee HY, Lee JJ, Chung JK, Im JG. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J Radiol. 2006;7:57-69. [PMID: 16549957 DOI: 10.3348/kjr.2006.07.1.57] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
215 Chang JM, Lee HJ, Goo JM, Lee HY, Lee JJ, Chung JK, Im JG. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J Radiol 2006;7:57-69. [PMID: 16549957 DOI: 10.3348/kjr.2006.7.1.57] [Cited by in Crossref: 201] [Cited by in F6Publishing: 224] [Article Influence: 11.8] [Reference Citation Analysis]
216 Pancreas. Advanced Imaging of the Abdomen. [DOI: 10.1007/1-84628-169-5_9] [Reference Citation Analysis]
217 Gorospe Sarasúa L, Echeveste Aizpurúa J, Raman S. Tomografía por emisión de positrones/tomografía computarizada: artefactos y pitfalls en pacientes con cáncer. Radiología 2006;48:189-204. [DOI: 10.1016/s0033-8338(06)73156-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
218 Cheow HK, Mikhaeel NG, O'Doherty MJ. PET and TNM: evolution or revolution? Nucl Med Commun 2006;27:101-3. [PMID: 16404221 DOI: 10.1097/01.mnm.0000199472.23654.bd] [Reference Citation Analysis]
219 Gorospe L, Raman S, Echeveste J, Avril N, Herrero Y, Herna Ndez S. Whole-body PET/CT: spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients. Nucl Med Commun. 2005;26:671-687. [PMID: 16000985 DOI: 10.1097/01.mnm.0000171779.65284.eb] [Cited by in Crossref: 85] [Cited by in F6Publishing: 91] [Article Influence: 5.0] [Reference Citation Analysis]
220 Zerbib E, Montravers F, Freneaux E, Baulieu F, Lebtahi R, Paycha F. Explorations radio-isotopiques en pathologie digestive. EMC - Radiologie et imagerie médicale - Abdominale - Digestive 2006;1:1-19. [DOI: 10.1016/s1879-8527(06)74698-6] [Reference Citation Analysis]
221 Montravers F, Zerbib E, Grahek D, Kerrou K, Younsi N, Talbot J. Tomographie par émission de positons au [18F]-fluorodésoxyglucose en cancérologie digestive. EMC - Radiologie et imagerie médicale - Abdominale - Digestive 2006;1:1-10. [DOI: 10.1016/s1879-8527(06)74699-8] [Reference Citation Analysis]
222 Oncology—Digestive Tract. Clinical PET and PET/CT. [DOI: 10.1007/1-84628-100-8_8] [Reference Citation Analysis]
223 Liu FY, Chen JS, Changchien CR, Yeh CY, Liu SH, Ho KC, Yen TC. Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels. Dis Colon Rectum 2005;48:1900-12. [PMID: 15991059 DOI: 10.1007/s10350-005-0097-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
224 Ruiz-hernández G, Delgado-bolton R, Rubio-pérez M, Jiménez-vicioso A, Pérez-castejón M, Carreras-delgado J. Recurrencia de un carcinoma gástrico de células en anillo de sello demostrada por PET-FDG. Revista Española de Medicina Nuclear 2005;24:326-30. [DOI: 10.1157/13079285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
225 Khandani AH, Semelka RC. Can the relation between gadopentetate dimeglumine and FDG uptake in colorectal liver metastases be used clinically? Radiology 2005;237:1-2. [PMID: 16183917 DOI: 10.1148/radiol.2371050766] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
226 Sahani DV, Kalva SP, Fischman AJ, Kadavigere R, Blake M, Hahn PF, Saini S. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. AJR Am J Roentgenol. 2005;185:239-246. [PMID: 15972430 DOI: 10.2214/ajr.185.1.01850239] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 4.8] [Reference Citation Analysis]
227 Delbeke D. Integrated PET-CT Imaging: Implications for Evaluation of Patients with Colorectal Carcinoma. Seminars in Colon and Rectal Surgery 2005;16:69-81. [DOI: 10.1053/j.scrs.2005.08.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
228 Herrero Y, Echeveste J, Gorospe L, Raman S, Gómez-león N. Evaluación mediante PET-TC de la respuesta al tratamiento selectivo de metástasis hepáticas en pacientes con cáncer de colon. Presentación de tres casos. Radiología 2005;47:160-164. [DOI: 10.1016/s0033-8338(05)72823-x] [Reference Citation Analysis]
229 Buyyounouski MK, Klump WJ, Konski A, Wu H, Adler LP. FDG PET imaging of signet-ring cell adenocarcinoma of the stomach. Clin Nucl Med 2005;30:118-9. [PMID: 15647683 DOI: 10.1097/00003072-200502000-00014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
230 Kalva SP, Sahani DV, Ryan D, Fischman AJ, Hahn PF, Mueller P, Saini S. Detection of liver metastases from gastrointestinal cancer: comparision of high resolution MnDPDP enhanced MRI and FDG-PET. Acad Radiol 2005;12 Suppl 1:S17-20. [PMID: 16106540 DOI: 10.1016/j.acra.2005.02.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
231 Gilman MD, Aquino SL. State-of-the-art FDG-PET imaging of lung cancer. Seminars in Roentgenology 2005;40:143-53. [DOI: 10.1053/j.ro.2005.01.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
232 Ruiz-hernández G, Delgado-bolton R, Fernández-pérez C, Lapeña L, Jiménez-vicioso A, Pérez-castejón MJ, Domper M, Montz R, Carreras Delgado J. Impacto de la tomografía por emisión de positrones mediante 18-Fluoro-2-Desoxi-D-Glucosa (PET-FDG) en el manejo terapéutico de pacientes con recurrencia secundaria a cáncer de ovario. Revista Española de Medicina Nuclear 2005;24:113-26. [DOI: 10.1157/13071687] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
233 Martínez-román S, Ramirez PT, Oh J, Gonzalez Viciedo M, Macapinlac HA. Combined positron emission tomography and computed tomography for the detection of recurrent ovarian mucinous adenocarcinoma. Gynecologic Oncology 2005;96:888-91. [DOI: 10.1016/j.ygyno.2004.10.045] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
234 Gámez C. Tomografía por emisión de positrones (PET/TC): presente y futuro de una nueva técnica de imagen en oncología. Cirugía Española 2005;77:111-3. [DOI: 10.1016/s0009-739x(05)70820-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
235 Sung YM, Lee KS, Kim B, Han J, Lee EJ. Lobar mucinous bronchioloalveolar carcinoma of the lung showing negative FDG uptake on integrated PET/CT. Eur Radiol 2005;15:2075-8. [DOI: 10.1007/s00330-004-2604-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
236 Zhou SM, Wong TZ, Marks LB. Using FDG-PET activity as a surrogate for tumor cell density and its effect on equivalent uniform dose calculation. Med Phys 2004;31:2577-83. [PMID: 15487740 DOI: 10.1118/1.1779372] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
237 Kayani I, Groves AM, Syed R, Bomanji J. Combined F-18 FDG Positron Emission Tomography/Computed Tomography in the Diagnosis of Colonic Polyps: The Potential and Limitations of the Technique. Clinical Nuclear Medicine 2005;30:116-7. [DOI: 10.1097/00003072-200502000-00013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
238 Truant S, Huglo D, Hebbar M, Ernst O, Steinling M, Pruvot F. Prospective evaluation of the impact of [18F]fluoro-2-deoxy- d -glucose positron emission tomography of resectable colorectal liver metastases. British Journal of Surgery 2005;92:362-9. [DOI: 10.1002/bjs.4843] [Cited by in Crossref: 96] [Cited by in F6Publishing: 98] [Article Influence: 5.3] [Reference Citation Analysis]
239 Nezu K, Sato Y, Matsui Y, Okumura S, Nakagawa K, Ishikawa Y. A Case of FDG-PET Positive Lung Cancer With Hilar Lymph Node Metastases, Which Showed False Negative FDG-PET Findings. JJLC 2005;45:381-386. [DOI: 10.2482/haigan.45.381] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
240 Chen J, Cheong J, Yun MJ, Kim J, Lim JS, Hyung WJ, Noh SH. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer 2005;103:2383-90. [DOI: 10.1002/cncr.21074] [Cited by in Crossref: 151] [Cited by in F6Publishing: 168] [Article Influence: 8.4] [Reference Citation Analysis]
241 Kluge R. Positronenemissionstomographie zur Diagnostik von Gallenblasen- und Gallenwegkarzinomen. Visc Med 2004;20:260-4. [DOI: 10.1159/000083010] [Reference Citation Analysis]
242 Hustinx R. PET imaging in assessing gastrointestinal tumors. Radiologic Clinics of North America 2004;42:1123-39. [DOI: 10.1016/j.rcl.2004.08.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
243 Delbeke D, Martin WH. PET and PET-CT for evaluation of colorectal carcinoma. Semin Nucl Med 2004;34:209-23. [PMID: 15202102 DOI: 10.1053/j.semnuclmed.2004.03.006] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 4.3] [Reference Citation Analysis]
244 Kawahara K, Yoshida Y, Kurokawa T, Suzuki Y, Nagahara K, Tsuchida T, Okazawa H, Fujibayashi Y, Yonekura Y, Kotsuji F. Evaluation of positron emission tomography with tracer 18-fluorodeoxyglucose in addition to magnetic resonance imaging in the diagnosis of ovarian cancer in selected women after ultrasonography. J Comput Assist Tomogr 2004;28:505-16. [PMID: 15232382 DOI: 10.1097/00004728-200407000-00011] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 1.8] [Reference Citation Analysis]
245 Dehdashti F, Siegel BA. Neoplasms of the esophagus and stomach. Seminars in Nuclear Medicine 2004;34:198-208. [DOI: 10.1053/j.semnuclmed.2004.03.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
246 Cheran SK, Nielsen ND, Patz EF Jr. False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications. AJR Am J Roentgenol 2004;182:1129-32. [PMID: 15100107 DOI: 10.2214/ajr.182.5.1821129] [Cited by in Crossref: 96] [Cited by in F6Publishing: 101] [Article Influence: 5.1] [Reference Citation Analysis]
247 Higashi T, Saga T, Nakamoto Y, Ishimori T, Fujimoto K, Doi R, Imamura M, Konishi J. Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) --usefulness and limitations in "clinical reality". Ann Nucl Med 2003;17:261-79. [PMID: 12932109 DOI: 10.1007/BF02988521] [Cited by in Crossref: 132] [Cited by in F6Publishing: 88] [Article Influence: 6.9] [Reference Citation Analysis]
248 Yasuda S, Nakai K, Ide M, Kawada S, Shohtsu A. PET in Surgery. PET and PET-CT in Oncology 2004. [DOI: 10.1007/978-3-642-18803-9_29] [Reference Citation Analysis]
249 Kitapci MT, Coleman RE. Colorectal Cancer. PET and PET-CT in Oncology 2004. [DOI: 10.1007/978-3-642-18803-9_20] [Reference Citation Analysis]
250 Cohade C, Wahl RL. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements. Semin Nucl Med. 2003;33:228-237. [PMID: 12931324 DOI: 10.1053/snuc.2003.127312] [Cited by in Crossref: 124] [Cited by in F6Publishing: 125] [Article Influence: 6.2] [Reference Citation Analysis]
251 Patrikeos AP, Mackay JR, Hicks RJ. Detection of Synchronous Adenocarcinomas and Multiple Dysplastic Polyps with F-18 FDG Positron Emission Tomography in a Case of Nonfamilial Polyposis: . Clinical Nuclear Medicine 2003;28:487-8. [DOI: 10.1097/01.rlu.0000067510.43457.52] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
252 Jadvar H, Tatlidil R, Garcia AA, Conti PS. Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. Clin Radiol. 2003;58:215-221. [PMID: 12639527 DOI: 10.1016/s0009-9260(02)00477-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
253 Yang M, Martin DR, Karabulut N, Frick MP. Comparison of MR and PET imaging for the evaluation of liver metastases. J Magn Reson Imaging 2003;17:343-9. [DOI: 10.1002/jmri.10265] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 2.5] [Reference Citation Analysis]
254 Vitola J, Delbeke D. Positron emission tomography for evaluation of colorectal carcinoma. Semin Roentgenol 2002;37:118-28. [PMID: 12134365 DOI: 10.1016/s0037-198x(02)80031-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
255 Pham KH, Ramaswamy MR, Hawkins RA. Advances in positron emission tomography imaging for the GI tract. Gastrointest Endosc 2002;55:S53-63. [PMID: 12024124 DOI: 10.1067/mge.2002.124741] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
256 Cohen MS, Arslan N, Dehdashti F, Doherty GM, Lairmore TC, Brunt LM, Moley JF. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery. 2001;130:941-946. [PMID: 11742321 DOI: 10.1067/msy.2001.118265] [Cited by in Crossref: 232] [Cited by in F6Publishing: 244] [Article Influence: 11.0] [Reference Citation Analysis]
257 Gámez Cenzano C, Cabrera Villegas A, Sopena Monforte R, García Velloso MJ. La tomografía por emisión de positrones (PET) en oncología (Parte I). Revista Española de Medicina Nuclear 2002;21:41-60. [DOI: 10.1016/s0212-6982(02)72033-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
258 Zealley IA, Skehan SJ, Rawlinson J, Coates G, Nahmias C, Somers S. Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet. Radiographics 2001;21 Spec No:S55-69. [PMID: 11598248 DOI: 10.1148/radiographics.21.suppl_1.g01oc05s55] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.3] [Reference Citation Analysis]
259 Nakamoto Y, Saga T, Ishimori T, Mamede M, Togashi K, Higuchi T, Mandai M, Fujii S, Sakahara H, Konishi J. Clinical Value of Positron Emission Tomography with FDG for Recurrent Ovarian Cancer. American Journal of Roentgenology 2001;176:1449-54. [DOI: 10.2214/ajr.176.6.1761449] [Cited by in Crossref: 109] [Cited by in F6Publishing: 116] [Article Influence: 5.0] [Reference Citation Analysis]
260 Strasberg SM, Dehdashti F, Siegel BA, Drebin JA, Linehan D. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Ann Surg. 2001;233:293-299. [PMID: 11224615 DOI: 10.1097/00000658-200103000-00001] [Cited by in Crossref: 135] [Cited by in F6Publishing: 146] [Article Influence: 6.1] [Reference Citation Analysis]